Dorkenoo, Monique Ameyo http://orcid.org/0000-0002-1030-7757
Tchankoni, Martin Kouame
Yehadji, Degninou
Yakpa, Kossi
Tchalim, Mawèké
Sossou, Efoe
Bronzan, Rachel
Ekouevi, Didier Koumavi
Funding for this research was provided by:
African Reasearch Network for NTD (SEC/0417/SGP_015)
Article History
Received: 16 September 2020
Accepted: 16 February 2021
First Online: 2 March 2021
Ethics approval and consent to participate
: Approval for this study was received from Togo MOH Bioethics Committee for Health Research of the Togo Ministry of Health (approval no. 390/2017/MSPS/CAB/SG/DGAS/DPML/CBRS). In addition, written informed consent was obtained from every adult enrolled and from the parent or guardian of each child enrolled in this study. No personal identification information has been reported. All persons testing positive by FTS and/or microfilaremia received a single dose of ivermectin plus albendazole according to WHO MDA dosing.
: Not applicable.
: The authors declare that they have no competing interests.